These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38059598)

  • 1. Zoledronic acid and ibandronate-induced nephrotoxicity in 2D and 3D proximal tubule cells derived from human and rat.
    Valencia LJ; Tseng M; Chu ML; Yu L; Adedeji AO; Kiyota T
    Toxicol Sci; 2024 Feb; 198(1):86-100. PubMed ID: 38059598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxic antisense oligonucleotide SPC5001 induces kidney injury biomarkers in a proximal tubule-on-a-chip.
    Nieskens TTG; Magnusson O; Andersson P; Söderberg M; Persson M; Sjögren AK
    Arch Toxicol; 2021 Jun; 95(6):2123-2136. PubMed ID: 33961089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity.
    Diekjürgen D; Grainger DW
    Arch Toxicol; 2019 May; 93(5):1349-1364. PubMed ID: 30863989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity.
    Weber EJ; Lidberg KA; Wang L; Bammler TK; MacDonald JW; Li MJ; Redhair M; Atkins WM; Tran C; Hines KM; Herron J; Xu L; Monteiro MB; Ramm S; Vaidya V; Vaara M; Vaara T; Himmelfarb J; Kelly EJ
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
    Sieber P; Lardelli P; Kraenzlin CA; Kraenzlin ME; Meier C
    Clin Drug Investig; 2013 Feb; 33(2):117-22. PubMed ID: 23184667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
    Diel IJ; Weide R; Köppler H; Antràs L; Smith M; Green J; Wintfeld N; Neary M; Duh MS
    Support Care Cancer; 2009 Jun; 17(6):719-25. PubMed ID: 19089462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.
    Diekjürgen D; Grainger DW
    Pflugers Arch; 2018 Sep; 470(9):1311-1323. PubMed ID: 29744639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphysiological system modeling of ochratoxin A-associated nephrotoxicity.
    Imaoka T; Yang J; Wang L; McDonald MG; Afsharinejad Z; Bammler TK; Van Ness K; Yeung CK; Rettie AE; Himmelfarb J; Kelly EJ
    Toxicology; 2020 Nov; 444():152582. PubMed ID: 32905824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
    Lühe A; Künkele KP; Haiker M; Schad K; Zihlmann C; Bauss F; Suter L; Pfister T
    Toxicol In Vitro; 2008 Jun; 22(4):899-909. PubMed ID: 18325729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity.
    Nieskens TTG; Persson M; Kelly EJ; Sjögren AK
    Drug Metab Dispos; 2020 Dec; 48(12):1303-1311. PubMed ID: 33020068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.
    Body JJ; Lichinitser M; Tjulandin S; Garnero P; Bergström B
    Ann Oncol; 2007 Jul; 18(7):1165-71. PubMed ID: 17442659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats.
    Pfister T; Atzpodien E; Bauss F
    Toxicology; 2003 Sep; 191(2-3):159-67. PubMed ID: 12965119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of CdCl2 and Cd-metallothionein in cultured rat kidney proximal tubules and LLC-PK1 cells.
    Liu J; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1994 Oct; 128(2):264-70. PubMed ID: 7940541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery and Transcriptome Assessment of an In Vitro Three-Dimensional Proximal Tubule Model Established by Human Kidney 2 Cells in Clinical Gelatin Sponges.
    Hsiao HY; Yen TH; Wu FY; Cheng CM; Liu JW; Fan YT; Huang JJ; Nien CY
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction.
    Gebremichael Y; Lu J; Shankaran H; Helmlinger G; Mettetal J; Hallow KM
    Toxicol Sci; 2018 Mar; 162(1):200-211. PubMed ID: 29126144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases.
    Luedders DW; Steinhoff J; Thill M; Rody A; Bohlmann MK
    Anticancer Res; 2015 Mar; 35(3):1797-802. PubMed ID: 25750345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bioartificial renal tubule device prepared with human renal proximal tubular epithelial cells cultured in serum-free medium.
    Takahashi H; Sawada K; Kakuta T; Suga T; Hanai K; Kanai G; Fujimura S; Sanechika N; Terachi T; Fukagawa M; Saito A
    J Artif Organs; 2013 Sep; 16(3):368-75. PubMed ID: 23666226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis.
    Hart A; Cesar F; Zelnick LR; O'Connor N; Bailey Z; Lo J; Van Ness K; Stanaway IB; Bammler TK; MacDonald JW; Thau MR; Himmelfarb J; Goss CH; Aitken M; Kelly EJ; Bhatraju PK
    J Cyst Fibros; 2024 Mar; 23(2):293-299. PubMed ID: 37949747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
    De Cock E; Hutton J; Canney P; Body JJ; Barrett-Lee P; Neary MP; Lewis G
    Clin Ther; 2005 Aug; 27(8):1295-310. PubMed ID: 16199254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.